The Supreme Court on Monday delivered a major blow to the drug industry’s effort to undercut the constitutionality of ...
The U.S. Supreme Court has declined to hear petitions from six major drugmakers challenging the Medicare Drug Price Negotiation Program, leaving in place lower court rulings that upheld the program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results